Initiative and drive: our management team
Steering Intravacc’s development and growth is a team of experienced industry and scientific experts. They bring initiative, knowledge, and leadership to all aspects of a successful vaccine-focused CDMO enterprise.
Ivo Lemmens
Director
Ivo Lemmens joined Intravacc in 2024 as Director. He is an experienced director who has a background in progressing companies in technology-driven industries. He is a professional in the field of strategy, finance, corporate development and coordinating complex projects. Ivo started his career at FDI, a Dutch innovation platform that consists of a group of high-end technological companies. Within FDI, he fulfilled several executive and non-executive director positions. Ivo holds a Bachelor’s degree in Business Economics and a Master’s degree in Finance.
Daniëlle Lankveld, DVM, PhD
Chief Operating Officer
Dr. Daniëlle Lankveld, DVM has been the COO since 2017. She joined Intravacc in 2013. She started her career as a veterinary anesthetist at the Veterinary School of Utrecht University in The Netherlands. In 2007 she became a researcher at the Dutch National Institute of Public Health. Subsequently, in 2011, she became the Manager of the Animal Research Center (ARC) of the former Netherlands Vaccine Institute. In 2013, when the ARC became part of Intravacc, she was promoted to the position of Chief Development Officer within Intravacc. She holds a degree as Doctor in Veterinary Medicine as well as a PhD from the University of Utrecht, The Netherlands.
Sabien van der Schoot,
Pharm D, PhD
Sr. Director Program Management
Sabien van der Schoot, Pharm D, PhD joined Intravacc in 2023 as Sr. Director Program Management. She is an experienced leader in the pharmaceutical industry. A pharmacist by training, she started her career with a PhD in the development and aseptic manufacturing of drug products for first-in-human clinical trials at the Dutch Cancer Institute. After that she held different positions in large pharmaceutical companies such as Solvay Pharmaceuticals, Abbott, and Janssen Vaccines. At these companies she held positions as senior scientist, CMC leader, and project leader, respectively. Prior to joining Intravacc, she was site leader of the Venn Life Sciences (part of hVIVO) consultancy office in Breda, The Netherlands, responsible for the business development strategy and reaching financial targets. Simultaneously she headed the CMC department.
Paul Ballering
Director Quality (QA/QC), Regulatory and ESH
Paul Ballering joined Intravacc in 2024 and is currently responsible for Quality (QA/QC), Regulatory and ESH (Environment, Safety, Health).
He is an experienced leader with a strong Lean Six Sigma drive and with over 26 years of GxP experience in positions of increasing responsibility in several (bio)pharmaceutical companies such as Diosynth, Organon, MSD Biotech and Byondis.
He held different management positions in laboratory, quality and compliance (including several health authority (approval) inspections), manufacturing and purification and CMC program/project management.
Paul has a BSc in Organic Chemistry.
Erik Popping, LLM
General Counsel
Erik Popping joined Intravacc in January 2016. He has over 15 years of experience within the pharmaceutical and healthcare sectors as a corporate and legal counsel. Before joining Intravacc, he was Corporate and Legal Counsel at the Hal Allergy Group, and, prior to that, for the Netherlands Vaccine Institute, a predecessor of Intravacc. He holds a Master's degree in Law from Radbound University and a Bachelor's degree in Business Administration from HAN University of Applied Sciences.
